Pseudolymphoma (reactive lymphoid hyperplasia) of the liver: A clinical challenge

Figure 1 Imaging findings of case 1. A: T2-weighted fat-saturated image showing focal mass (indicated by arrow) in segment 2 with increased signal intensity as compared to background liver; B: T1-weighted fat-saturated image showing focal mass with decreased signal intensity as compared to background liver; C: T1-weighted fat-saturated image after contrast infusion in the late arterial phase. The mass is hypervascular on this phase; D: T1-weighted fat-saturated image after contrast infusion in the portal venous phase. The mass washes out on this phase. A capsule is seen; E: Positron emission tomography scan shows hypermetabolic activity; F: T1-weighted fat-saturated image 20 min after hepatocellular contrast, Gadoxetate Disodium (Eovist) infusion. Lesion does not take up Eovist.